Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
EJNMMI Research
Published in: EJNMMI Research 1/2019

Open Access 01-12-2019 | Positron Emission Tomography | Original research

Optimising quantitative 90Y PET imaging: an investigation into the effects of scan length and Bayesian penalised likelihood reconstruction

Authors: Nathaniel P. Scott, Daniel R. McGowan

Published in: EJNMMI Research | Issue 1/2019

Login to get access

Abstract

Background

Positron emission tomography (PET) imaging of 90Y following selective internal radiation therapy (SIRT) is possible, but image quality is poor, and therefore, accurate quantification and dosimetry are challenging. This study aimed to quantitatively optimise 90Y PET imaging using a new Bayesian penalised likelihood (BPL) reconstruction algorithm (Q.Clear, GE Healthcare). The length of time per bed was also investigated to study its impact on quantification accuracy.

Methods

A NEMA IQ phantom with an 8:1 sphere-to-background ratio was scanned overnight on a GE Discovery 710 PET/CT scanner. Datasets were rebinned into varying lengths of time (5–60 min); the 15-min rebins were reconstructed using BPL reconstruction with a range of noise penalisation weighting factors (beta values). The metrics of contrast recovery (CR), background variability (BV), and recovered activity percentage (RAP) were calculated in order to identify the optimum beta value. Reconstructions were then carried out on the rest of the timing datasets using the optimised beta value; the same metrics were used to assess the quantification accuracy of the reconstructed images.

Results

A beta value of 1000 produced the highest CR and RAP (76% and 73%, 37 mm sphere) without overly accentuating the noise (BV) in the image. There was no statistically significant increase (p < 0.05) in either the CR or RAP for scan times of > 15 min. For the 5-min acquisitions, there was a statistically significant decrease in RAP (28 mm sphere, p < 0.01) when compared to the 15-min acquisition.

Conclusion

Our results indicate that an acquisition length of 15 min and beta value of 1000 (when using Q.Clear reconstruction) are optimum for quantitative 90Y PET imaging. Increasing the acquisition time to more than 15 min reduces the image noise but has no significant impact on image quantification.
Appendix
Available only for authorised users
Literature
1.
Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. J Vasc Interv Radiol. 2006;17(9):1425–39.CrossRef
2.
Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med. 2010;51(8):1206–12.CrossRef
3.
Leung TWT, Lau WY, Ho SKW, Ward SC, Chow JHS, Chan MSY, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33(4):919–24.CrossRef
4.
Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with Yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31(5):431–8.CrossRef
5.
Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18(4):553–61.CrossRef
6.
Gates VL, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, Nemcek AA, et al. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Future Oncol. 2007;3:73–81.CrossRef
7.
Dezarn WA, Cessna JT, Dewerd LA, Feng W, Gates VL, Halama J, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys. 2011;38(8):4824–45.CrossRef
8.
Garin E, Rolland Y, Laffont S, Edeline J. Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with90Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 2016;43(3):559–75.CrossRef
9.
Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53(2):255–63.CrossRef
10.
Wondergem M, Smits MLJ, Elschot M, de Jong HWAM, Verkooijen HM, van den Bosch MAAJ, et al. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med. 2013;54(8):1294–301.CrossRef
11.
Jiang M, Fischman A, Nowakowski FS. Segmental perfusion differences on paired Tc-99m macroaggregated albumin (MAA) hepatic perfusion imaging and Yttrium-90 (Y-90) bremsstrahlung imaging studies in SIR-sphere radioembolization: associations with angiography. J Nucl Med Radiat Ther. 2012;03(01):1–5.CrossRef
12.
D’Arienzo M. Emission of β+ particles via internal pair production in the 0+ − 0+ transition of 90Zr: historical background and current applications in nuclear medicine imaging. Atoms. 2013;1(1):2–12.CrossRef
13.
Wright CL, Zhang J, Tweedle MF, Knopp MV, Hall NC. Theranostic imaging of Yttrium-90. Biomed Res Int. 2015;2015:1–11.
14.
Kao Y-H, Steinberg JD, Tay Y-S, Lim GK, Yan J, Townsend DW, et al. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. EJNMMI Res. 2013;3(1):56.CrossRef
15.
Willowson KP, Tapner M, Bailey DL, Bailey DL. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres. Eur J Nucl Med Mol Imaging. 2015;42(8):1202–22.CrossRef
16.
Miller TR, Wallis JW. Clinically important characteristics of maximum-likelihood reconstruction. J Nucl Med. 1992;33(9):1678–84.PubMed
17.
Teoh EJ, McGowan DR, Macpherson RE, Bradley KM, Gleeson FV. Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system. J Nucl Med. 2015;56(9):1447–52.CrossRef
18.
Teoh EJ, McGowan DR, Bradley KM, Belcher E, Black E, Gleeson FV. Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules. Eur Radiol. 2016;26(2):576–84.CrossRef
19.
Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases? Eur J Radiol. 2015;84(10):1873–8.CrossRef
20.
Chilcott AK, Bradley KM, McGowan DR. Effect of a Bayesian penalized likelihood PET reconstruction compared with ordered subset expectation maximization on clinical image quality over a wide range of patient weights. Am J Roentgenol. 2018.
21.
Rowley LM, Bradley KM, Boardman P, Hallam A, McGowan DR. Optimization of image reconstruction for 90 Y selective internal radiotherapy on a lutetium yttrium Orthosilicate PET/CT system using a Bayesian penalized likelihood reconstruction algorithm. J Nucl Med. 2017;58(4):658–64.CrossRef
22.
Goedicke A, Berker Y, Verburg FA, Behrendt FF, Winz O, Mottaghy FM. Study-parameter impact in quantitative 90-yttrium PET imaging for radioembolization treatment monitoring and dosimetry. IEEE Trans Med Imaging. 2013;32(3):485–92.CrossRef
23.
European Parliament. Council directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom a. Off J Eur Commun L13. 2014;1–73.
Metadata
Title
Optimising quantitative 90Y PET imaging: an investigation into the effects of scan length and Bayesian penalised likelihood reconstruction
Authors
Nathaniel P. Scott
Daniel R. McGowan
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2019
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/s13550-019-0512-y

Other articles of this Issue 1/2019

EJNMMI Research 1/2019 Go to the issue

Preliminary research

99mTc-HYNIC-IL-2 scintigraphy to detect acute rejection in lung transplantation patients: a proof-of-concept study

Original research

What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours

Original research

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

Original research

Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study

Original research

A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer

Original research

Bone SPECT-based segmented attenuation correction for quantitative analysis of bone metastasis (B-SAC): comparison with CT-based attenuation correction